User profiles for Gemma Moncunill

Gemma Moncunill

Assistant Research Professor, ISGlobal
Verified email at isglobal.org
Cited by 3758

[HTML][HTML] Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

AL Garcia-Basteiro, G Moncunill, M Tortajada… - Nature …, 2020 - nature.com
Health care workers (HCW) are a high-risk population to acquire SARS-CoV-2 infection
from patients or other fellow HCW. This study aims at estimating the seroprevalence against …

[HTML][HTML] Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses

…, P Engel, AL García-Basteiro, G Moncunill… - Nature …, 2021 - nature.com
Unraveling the long-term kinetics of antibodies to SARS-CoV-2 and the individual characteristics
influencing it, including the impact of pre-existing antibodies to human coronaviruses …

[HTML][HTML] The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind …

…, JC Gabaldón-Figueira, C Dobaño, G Moncunill… - …, 2021 - thelancet.com
Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not
readily achievable with currently approved doses. There is limited evidence to support its …

SARS-CoV-2 seroprevalence and antibody kinetics among health care workers in a Spanish hospital after 3 months of follow-up

G Moncunill, A Mayor, R Santano… - The Journal of …, 2021 - academic.oup.com
Background At the COVID-19 spring 2020 pandemic peak in Spain, prevalence of SARS-CoV-2
infection in a cohort of 578 randomly selected health care workers (HCWs) from Hospital …

[HTML][HTML] Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain

M Ribes, C Chaccour, G Moncunill - Signal Transduction and Targeted …, 2021 - nature.com
In a recent report in Science, McCarthy et al. promptly observed a pattern of recurrent
deletions in four discrete regions of the N-terminal Domain (NTD) of the Spike protein, which …

[HTML][HTML] Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers

G Moncunill, R Aguilar, M Ribes, N Ortega, R Rubio… - …, 2022 - thelancet.com
Background Two doses of mRNA vaccination have shown >94% efficacy at preventing
COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize …

Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A, and G against SARS-CoV-2 antigens

…, L Izquierdo, R Aguilar, G Moncunill - Journal of clinical …, 2021 - Am Soc Microbiol
Reliable serological tests are required to determine the prevalence of antibodies against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to characterize immunity …

The RTS, S malaria vaccine: Current impact and foundation for the future

…, D Mathanga, C Dobano, G Moncunill - Science Translational …, 2022 - science.org
The RTS,S vaccine has recently been recommended for implementation as a childhood
vaccine in regions with moderate-to-high malaria transmission. We discuss mechanisms of …

[HTML][HTML] Improving vaccine-induced immunity: can baseline predict outcome?

JS Tsang, C Dobaño, P VanDamme, G Moncunill… - Trends in …, 2020 - cell.com
Immune signatures measured at baseline and immediately prior to vaccination may predict
the immune response to vaccination. Such pre-vaccine assessment might allow not only …

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies

…, AL García-Basteiro, R Aguilar, G Moncunill… - Translational …, 2021 - Elsevier
COVID-19 patients elicit strong responses to the nucleocapsid (N) protein of SARS-CoV-2
but binding antibodies are also detected in prepandemic individuals, indicating potential …